Finch Therapeutics Group, Inc.
FNCH · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,834 | -$3,876 | -$3,041 | -$2,416 |
| Dep. & Amort. | $0 | $43 | $44 | $52 |
| Deferred Tax | $0 | $0 | -$419 | $22 |
| Stock-Based Comp. | $15 | $28 | $114 | $335 |
| Change in WC | -$528 | -$1,123 | -$786 | -$3,973 |
| Other Non-Cash | $621 | $566 | $382 | $719 |
| Operating Cash Flow | -$4,726 | -$4,362 | -$3,706 | -$5,261 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $14 | $0 |
| Net Acquisitions | $0 | $0 | $37 | $20 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $20 |
| Investing Cash Flow | $0 | $0 | $51 | $20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$1,155 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1,155 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | -$1 | $0 |
| Net Chg. in Cash | -$4,726 | -$4,362 | -$3,655 | -$5,242 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,110 | $25,124 | $28,779 | $36,369 |
| End Cash | $18,384 | $20,762 | $25,124 | $31,127 |
| Free Cash Flow | -$4,726 | -$4,362 | -$3,692 | -$5,261 |